MADRIGAL PHARMACEUTICALS, INC. (MDGL) Total liabilities 2012–2025
MADRIGAL PHARMACEUTICALS, INC. (MDGL) total liabilities at each fiscal year-end, per SEC filings.
$656.9MFY2025 · since FY2012: $28.0M → $656.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $656.9M | +128.2% |
| FY2024 | $287.9M | +22.4% |
| FY2023 | $235.2M | +42.4% |
| FY2022 | $165.2M | +113.9% |
| FY2021 | $77.2M | +64.2% |
| FY2020 | $47.0M | +84.5% |
| FY2019 | $25.5M | +201.9% |
| FY2018 | $8.4M | -16.0% |
| FY2017 | $10.1M | — |
| FY2012 | $28.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice